Fragment-Based Discovery of First-In-Class Small-Molecule Kinase Inhibitors for Targeted Cancer Therapies( I )( I )

Pharmacology, Toxicology and Pharmaceutical Science

1. Malignant Neoplasm 100%
2. Phosphotransferase Inhibitor 100%
3. Phosphotransferase 75%
4. Drug Discovery 75%
5. Anticarcinogen 50%
6. Lead Compound 50%
7. Structure Activity Relationship 50%
8. Cytotoxicity 50%
9. Compounds of Lead 25%
10. Preclinical Study 25%
11. Bioassay 25%
12. Pharmaceutical Chemistry 25%
13. Tumor Growth 25%
14. Pharmacological Activity 25%
15. Base 25%
16. Anticancer Drug 25%